News and Insights

Pharmaceuticals and Medical Devices

The Impact of Covid-19 on Manufacturers’ Commercial Model

In response to Covid-19, manufacturers have quickly adapted their commercial approaches. But which of those changes are permanent? What additional capabilities do organizations need to succeed in the “new normal”? What has Covid-19 shown us about weaknesses in the traditional commercial model? To understand the extent to which the pandemic…

The Numerof 2021 Global Medical Device Outlook

Infographic

As our Numerof 2021 Global Medical Device Outlook infographic illustrates, this year’s story for medical device manufacturers will be about continuing to adapt to pressures on price and demands for value. You’ll continue to engage in new and different ways with healthcare delivery, physicians, regulators, public and private payers, consumers,…

The Numerof 2021 Global Pharma Outlook

Infographic

As our Numerof 2021 Global Pharma Outlook infographic illustrates, this year’s story for pharmaceutical manufacturers will be about continuing to adapt to pressures on price and demands for value while also addressing new challenges presented by the pandemic. This will create the need for changes in current roles and external…

Covid-19 Accelerates the Need for a New Commercial Model

As leadership focuses on the trauma of Covid-19 across healthcare delivery and the challenges it presents, it is easy to forget that the traditional commercial model was under serious stress before the pandemic. Consolidation across delivery, changes in product decision-making, and growing limitations on access were making that model increasingly…